Optical coherence tomography in optic neuritis and multiple sclerosis: A review

European Journal of Neurology

Volumn 14, Issue 8, 2007, Pages 841-849

  Kallenbach, K ^a   Frederiksen, J ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Demyelinating diseases; Multiple sclerosis; Neuroimmunology; Neuroophthalmology; SSPE; Vision and ocular movements

Indexed keywords

AMPLITUDE MODULATION; ATROPHY; COLOR VISION; CONTRAST SENSITIVITY; CORRELATION ANALYSIS; EVOKED RESPONSE; EVOKED VISUAL RESPONSE; HEALTH SURVEY; HUMAN; MEDLINE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; VISUAL ACUITY; VISUAL FIELD;

ATROPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NERVE DEGENERATION; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; RETINA; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 34547123798     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01736.x     Document Type: Review

References (38)

1. Frederiksen JL. A prospective study of acute optic neuritis: clinical, MRI, CSF, neurophysiological and HLA findings. Thesis. Copenhagen, Denmark. FADL's Forlag.
2. Sørensen TL, Frederiksen JL, Brønnum-Hansen H, Petersen HC. Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. American Academy of Neurology 1999 53 : 473 478.
3. Söderström M, Jin YP, Hillert J, Link H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. American Academy of Neurology 1998 50 : 708 714.
4. Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Archives of Ophthalmology 2003 121 : 944 949.
5. Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. American Journal of Ophthalmology 2004 137 : 77 83.
6. Optic Neuritis Study Group. The clinical profile of optic neuritis. Archives of Ophthalmology 1991 109 : 1673 1678.
7. Balcer LJ, Baier ML, Cohen JA, et al. Contrast letter acuity as a visual component for the multiple sclerosis functional composite. Neurology 2003 61 : 1367 1373.
8. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology 2005 64 : 992 995.
9. Balcer LJ, Baier ML, Pelak VS, et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Multiple Sclerosis 2000 6 : 163 171.
10. Trobe JD, Beck RW, Moke PS, Cleary PA. Contrast sensitivity and other vision tests in the Optic Neuritis Treatment Trial. American Journal of Ophthalmology 1996 121 : 547 553.
11. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurology 2006 5 : 158 170.
12. Anderson VM, Fox NC, Miller D. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. Journal of Magnetic Resonance Imaging 2006 23 : 605 618.
13. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transaction in the lesions of multiple sclerosis. The New England Journal of Medicine 1998 338 : 278 285.
14. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997 120 : 393 399.
15. Quigley HA, Davis EB, Anderson DR. Descending optic nerve degeneration in primates. Investigative Ophthalmology and Visual Science 1977 16 : 841 849.
16. Rieckman P. Neurodegeneration and clinical relevance for early treatment in multiple sclerosis. The International MS Journal 2005 12 : 42 51.
17. Schmitt JM. Optical coherence tomography (OCT): a review. IEEE Journal of Selected Topics in Quantum Electronics 1999 5 : 1205 1215.
18. Ishikawa H, Stein DM, Wolstein G, Beaton S, Fujimoto JG, Schuman JS. Macular segmentation with optical coherence tomography. Investigative Ophthalmology and Visual Science 2005 46 : 2012 2017.
19. Kanamori A, Nakamura M, Escano MFT, Seya R, Maeda H, Negi A. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. American Journal of Ophthalmology 2003 135 : 513 520.
20. Sihota R, Sony P, Gupta V, Dada T, Singh R. Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Investigative Ophthalmology and Visual Science 2006 47 : 2006 2010.
21. Jeoung JW, Park KH, Kim TW, Khwarg SI, Kim DM. Diagnostic ability of optical coherence tomography with a normative database to detect localized retinal nerve fiber layer defects. Ophthalmology 2005 112 : 2157 2163.
22. Budenz DL, Chang RT, Huang X, Knighton RW, Tielsch JM. Reproducibility of retinal nerve fiber thickness measurements using the Stratus OCT in normal and glaucomatous eyes. Investigative Ophthalmology and Visual Science 2005 46 : 2440 2443.
23. Hougaard JL, Ostenfeld C, Heijl A, Bengtsson B. Modelling the normal retinal nerve fibre layer thickness as measured by Stratus optical coherence tomography. Graefe's Archive for Clinical and Experimental Ophthalmology 2006 [Epub ahead of print].
24. Sergott RC, Piette S, Etter J, Savino PJ, Affel L. In Vivo Neuroprotection with High-Dose, High-Frequency Interferon therapy: A Serial Optical Coherence Tomography study in Multiple Sclerosis and Optic Neuritis. Poster No. P251. Presented at the 21st Congress of the ECTRIMS. Thessaloniki, Greece, 29 September, 2005.
25. Sergott RC. Optical coherence tomography: Measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Current Opinion in Ophthalmology 2005 16 : 346 350.
26. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Investigative Ophthalmology and Visual Science 1999 40 : 2520 2527.
27. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Annals of Neurology 2005 58 : 383 391.
28. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006 113 : 324 332.
29. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Annals of Neurology 2006 59 : 963 969.
30. Menke MN, Feke GT, Trempe CL. OCT measurements in patients with optic disc edema. Investigative Ophthalmology and Visual Science 2005 46 : 3807 3811.
31. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fiber layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. NeuroImage 2006 31 : 286 293.
32. Kerrison JB, Flynn T, Green R. Retinal pathologic changes in multiple sclerosis. Retina 1994 14 : 445 451.
33. Hickman SJ, Toosy AT, Jones SJ, et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004 127 : 2498 2505.
34. Toth CA, Narayan DG, Boppart ST, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Archives of Ophthalmology 1997 115 : 1425 1428.
35. Chauhan DS, Marshall J. The interpretation of optical coherence tomography images of the retina. Investigative Ophthalmology and Visual Science 1999 40 : 2332 2342.
36. Skaf M, Bernardes AB, Cardillo JA, et al. Retinal nerve fibre layer thickness profile in normal eyes using third-generation optical coherence tomography. Eye 2006 20 : 431 439.
37. Frederiksen JL, Sørensen TL, Sellebjerg FT. Residual symptoms and signs after untreated acute optic neuritis. Acta Ophthalmologica Scandinavica 1997 75 : 544 547.
38. Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. Journal of the American Society for Experimental Neurotherapeutics 2004 1 : 284 294.